Sign up to save your podcasts
Or
Share Quantitative 68Ga-PSMA-11 PET and Outcomes in Metastatic Castration-resistant Prostate Cancer following 177Lu-PSMA-617
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Quantitative 68Ga-PSMA-11 PET and Outcomes in Metastatic Castration-resistant Prostate Cancer following 177Lu-PSMA-617
Dr. Ashwin Singh Parihar speaks with Dr. Phillip Kuo, Dr. Andrew Armstrong, and Dr. Ken Herrmann about how 68Ga-PSMA-11 PET can predict response of metastatic prostate cancer following 177Lu-PSMA-617 therapy. The VISION Trial.
Quantitative 68Ga-PSMA-11 PET and ClinicalOutcomes in Metastatic Castration-resistant ProstateCancer Following 177Lu-PSMA-617 (VISION Trial). Kuo and Morris et al. Radiology 2024; 312(2):e233460.
View all episodes
By The Radiological Society of North America
4.7
8484 ratings
Dr. Ashwin Singh Parihar speaks with Dr. Phillip Kuo, Dr. Andrew Armstrong, and Dr. Ken Herrmann about how 68Ga-PSMA-11 PET can predict response of metastatic prostate cancer following 177Lu-PSMA-617 therapy. The VISION Trial.
Quantitative 68Ga-PSMA-11 PET and ClinicalOutcomes in Metastatic Castration-resistant ProstateCancer Following 177Lu-PSMA-617 (VISION Trial). Kuo and Morris et al. Radiology 2024; 312(2):e233460.
More shows like Radiology Podcasts | RSNA
View all
AJNR Podcasts
28 Listeners
Freakonomics Radio
32,174 Listeners
NEJM This Week
324 Listeners
JAMA Clinical Reviews
493 Listeners
Radiology Lectures | Radquarters
77 Listeners
White Coat Investor Podcast
2,428 Listeners
JAMA Medical News
87 Listeners
RadioGraphics Podcasts | RSNA
28 Listeners
AJR Podcasts
43 Listeners
The Prof G Pod with Scott Galloway
5,295 Listeners
The Radiology Review Podcast
202 Listeners
Radiology AI Podcasts | RSNA
13 Listeners
The Radiology Report Podcast
10 Listeners
NEJM AI Grand Rounds
49 Listeners
The Radiopaedia Reading Room Podcast
41 Listeners